IP Library Assignment 042821/0566
Patent Assignment
Reel/Frame 042821/0566

Assignment of Assignor's Interest

Recorded: 2017-06-27 Pages: 10
Assignors
LYSSIKATOS, JOSEPH P.
Executed: 2008-09-02
GRESCHUK, JULIE MARIE
Executed: 2008-09-04
HENNINGS, D. DAVID
Executed: 2008-08-22
LIU, WEIDONG
Executed: 2008-08-22
MARMSATER, FREDRIK P.
Executed: 2008-09-04
ZHANG, QIAN
Executed: 2008-09-04
Assignee
ARRAY BIOPHARMA, INC.
3200 WALNUT STREET, BOULDER, COLORADO, 80301
Covered Properties (2)
N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as Erbb Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
Application: 15/599,867 →
Publication: US 2017/0252317
N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as Erbb Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
Patent: 9,693,989 →
Application: 14/034,361 →
Publication: US 2014/0023643
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 27, 2017
From: LYSSIKATOS, JOSEPH P.; MARMSATER, FREDRIK; ZHAO, QIAN; GRESCHUK, JULIE MARIE
To: ARRAY BIOPHARMA, INC.
Reel/Frame 042821/0512 →